Rottenstein Law Group Reports Acceleration of New Jersey Fosamax Femur Fracture Trial Schedule

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has learned that the first New Jersey state court trials of cases involving femur fractures alleged to be caused by the drug will precede further trials of cases involving other alleged harms.

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend

The Rottenstein Law Group, LLP

New York, NY (PRWEB) June 18, 2012

The Rottenstein Law Group, which represents clients with claims stemming from the severe side effects of the drug Fosamax, has learned that the first New Jersey state court trials of cases involving femur fractures alleged to be caused by the drug will precede further trials of cases involving other alleged harms.

By letter dated June 4, 2012, Superior Court of New Jersey Judge Carol E. Higbee informed counsel for parties to the consolidated Fosamax litigation before her (Case No. 282) that rather than try another osteonecrosis of the jaw (ONJ) case next, she will “move to the trial of bellwether cases involving femur fractures.” Judge Higbee had intended to assign a second ONJ case for trial to a judge who is now going to be transferred to a different division of the court; no other judge is available to try the case that was going to come up next. Instead, that case will be “placed on hold,” and “[i]n the interest of advancing the entire Fosamax litigation,” Judge Higbee will be conferring with counsel to finalize selection of the first femur fracture cases to be tried.

Despite being the most popular osteoporosis treatment medication on the market, Fosamax has been linked to several serious side effects. In 2004, researchers found a causal connection between Fosamax and osteonecrosis of the jaw, a condition where the jawbone dies due to a lack of blood supply. More recently, people have suffered low-impact femur fractures after falling from standing height or less. Evidence is building that taking Fosamax or similar medications for the treatment of osteoporosis causes a dramatic increase in risk of this particular kind of rare fracture to the thigh bone.

The Rottenstein Law Group urges anyone whose friend or relative has been prescribed Fosamax or another osteoporosis drug to reach out to that person and recommend that he or she consult a physician immediately and then speak to a qualified personal injury lawyer. The Rottenstein Law Group maintains a Fosamax Femur Fracture Lawsuit Information Center at http://www.fosamaxfemurfracturelawsuit.com. The site has features that allow for easy sharing, including links for automatic posting on Facebook and Twitter, specifically to enable visitors to spread the word about the dangers of Fosamax.

About THE ROTTENSTEIN LAW GROUP
The Rottenstein Law Group is a New York-based law firm that represents clients in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients in consumer product injury, mass tort, and class action lawsuits in a compassionate manner. http://www.rotlaw.com

Contact:
The Rottenstein Law Group, LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
Suite 511
New York, New York 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com
http://www.rotlaw.com


Contact